Bioscompass Acquires Anti-Adhesion Gel (Orthopedics This Week)
Rochester, Minnesota-based BiosCompass, Inc. has acquired the IP (intellectual property) for Adcon Gel from AaP Implanate AG and EMCM B.V.
The product is a biocompatible, resorbable gel that provides a physical barrier to inter-tissue adhesions by inhibiting fibroblast migration onto and around neural or tendinous structures.
According to the company, the design of the gel is based on the concept of establishing a temporary basal lamina by combining an absorbable, collagen-derived material with a resorbable polyglycan ester. A major function of basal lamina is to provide a physical barrier to certain cells and molecules (including fibroblasts). Adcon Gel is the combination of polyglycan ester with porcine gelatine and buffered saline.
BiosCompass CEO Fred Hardwick said, “Years ago I would have given anything just to sell Adcon Gel as a commission rep in Birmingham, Alabama. Today we own it. We feel proud but humble, as if we are newly adoptive parents of a brilliantly gifted child. We are intent on relaunching Adcon Gel in the U.S. market as we continue to grow and help more surgeons and patients around the world preven...
